| Factor Information | |
|---|---|
| Data ID | 2965 |
| Factor | using warfarin(%) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | prognostic implications of hyponatraemia in ACHD |
| p Value | 0.02 |
| Conclusion | The ration of patients using Warfarin was significantly higher in patients with hyponatraemia |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 642 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
| Reference | |
|---|---|
| PMID | 19933692 |
| Year | 2010 |
| Title | Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | patients' data | |
| Region | London, UK | |
| Method | univariable analysis logsitic regression | |
| Race | British | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ACHD with sodium <136mmol/L(Treatment) | ACHD with sodium >136mmol/L(Control) |
| Number | 53 | 207 |
| Age | 37.4±15.8 | 35.9±14.1 |
| Gender (Male: Female) | 73:83 | 416:432 |
| Marker Level | 53(34%)(ACHD with sodium <136mmol/L) | 207(24.4%)(ACHD with sodium >136mmol/L) |
